Neutralizing inter-clade cross-reactivity of HIV-1 V1/V2-specific secretory immunoglobulin A in Colombian and French cohorts-Reference-Cited by-同舟云学术

Neutralizing inter-clade cross-reactivity of HIV-1 V1/V2-specific secretory immunoglobulin A in Colombian and French cohorts

Published:2009-10-23 Issue:16 Volume:23 Page:2219-2222
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Granados-Gonzalez Viviana,Piedrahita Leidy Diana,Martinez-Gutierrez Marlen,Lawrence Philip,Saoudin Henia,Zapata Ximena,Lucht Frederic,Pinter Abraham,Genin Christian,Urcuqui-Inchima Silvio,Riffard Serge

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference28 articles.

1. Antibody neutralization and escape by HIV-1;Wei;Nature,2003

2. HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites;Kwong;Nature,2002

3. HIV vaccine design and the neutralizing antibody problem;Burton;Nat Immunol,2004

4. Analysis of polymorphism in the protease and reverse transcriptase genes of HIV type 1 CRF02-AG subtypes from drug-naive patients from Saint-Etienne, France;Lawrence;J Acquir Immune Defic Syndr,2006

5. Secretory IgA specific for a conserved epitope on gp41 envelope glycoprotein inhibits epithelial transcytosis of HIV-1;Alfsen;J Immunol,2001

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unusual Cysteine Content in V1 Region of gp120 From an Elite Suppressor That Produces Broadly Neutralizing Antibodies;Frontiers in Immunology;2019-05-15

2. Secretory IgA specific for MPER can protect from HIV-1 infection in vitro;AIDS;2013-07-31

3. The potential global market size and public health value of an HIV-1 vaccine in a complex global market;Vaccine;2010-07

4. HIV-1-specific antibody responses during acute and chronic HIV-1 infection;Current Opinion in HIV and AIDS;2009-09